Anaplastic Ependymoma and Atypical Refractory Longitudinal Expansive Transverse Myelitis Due to Immune Reaction After COVID-19-A Case Discussion That Raises Many Unknown Questions About Covid-19

Simple item page
dc.contributor.authorGemici, YI
dc.contributor.authorÇelik, F
dc.contributor.authorGöz, ZZ
dc.contributor.authorIsisag, A
dc.contributor.authorOvali, GY
dc.contributor.authorZileli, M
dc.contributor.authorBarutçuoglu, M
dc.contributor.authorMavioglu, H
dc.date.accessioned2025-04-10T10:32:37Z
dc.date.available2025-04-10T10:32:37Z
dc.description.abstractInflammatory neurologic manifestations, both infectious and noninfectious, have been reported secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19). However, the relationship of spinal tumor and COVID-19 longitudinally extensive transverse myelitis (LETM) coexistence has never been reported in our knowledge. The clinical presentation and response to treatment of a 24-year-old female patient diagnosed with COVID-19 LETM and anaplastic ependymoma are described in this case report. The Patient's cerebrospinal fluid COVID-19 antibody level was higher than serum , she was resistant to immunosuppressive treatment. The interaction between COVID-19 and spinal tumor was discussed in the light of the literature. It is thought that COVID-19 infection could trigger tumor growth in this patient. Also, this is the first case of anaplastic ependymoma and COVID-19 myelitis coexistence in the literature.
dc.identifier.e-issn1309-4866
dc.identifier.issn1300-0667
dc.identifier.urihttp://hdl.handle.net/20.500.14701/38980
dc.language.isoEnglish
dc.titleAnaplastic Ependymoma and Atypical Refractory Longitudinal Expansive Transverse Myelitis Due to Immune Reaction After COVID-19-A Case Discussion That Raises Many Unknown Questions About Covid-19
dc.typeArticle

Files

Collections

Web of Science Koleksiyonu